Zealand Pharma A/S (LON:0NZU)
403.40
-16.85 (-4.01%)
At close: Feb 11, 2026
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 3.31 billion as of February 12, 2026. Its market cap has decreased by -46.67% in one year.
Market Cap
3.31B
Enterprise Value
1.47B
Revenue
1.07B
Ranking
n/a
PE Ratio
4.33
Stock Price
403.40
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 159.84M to 3.31B, an increase of 1,970.06%. That is a compound annual growth rate of 22.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.31B | -13.85% |
| Dec 30, 2025 | 3.84B | -31.68% |
| Dec 30, 2024 | 5.62B | 121.65% |
| Dec 29, 2023 | 2.54B | 105.19% |
| Dec 30, 2022 | 1.24B | 74.70% |
| Dec 30, 2021 | 707.55M | -33.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harbour Energy | 3.70B |
| Balfour Beatty | 3.62B |
| easyJet | 3.60B |
| Hochschild Mining | 3.55B |
| Hikma Pharmaceuticals | 3.43B |
| Rightmove | 3.37B |
| Plus500 | 3.37B |
| RS Group | 3.35B |